Threshold Pharmaceuticals - logo

Threshold Pharmaceuticals - Company & Market Research Reports

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021: Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape - Product Thumbnail Image

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021: Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

  • Report
  • 138 Pages
From
Liver Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H2 2016

  • Drug Pipelines
  • 1171 Pages
From
Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Therapeutic, by Diagnostic and Geography - Growth, Trends and Forecasts (2018 - 2023) - Product Thumbnail Image

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Therapeutic, by Diagnostic and Geography - Growth, Trends and Forecasts (2018 - 2023)

  • Report
  • 115 Pages
From
North America Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022 - Product Thumbnail Image

North America Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022

  • Report
  • 120 Pages
From
Middle East & Africa Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022 - Product Thumbnail Image

Middle East & Africa Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022

  • Report
  • 120 Pages
From
Latin America Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022 - Product Thumbnail Image

Latin America Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022

  • Report
  • 212 Pages
From
Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022 - Product Thumbnail Image

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022

  • Report
  • 120 Pages
From
Europe Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022 - Product Thumbnail Image

Europe Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022

  • Report
  • 120 Pages
From
Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022 - Product Thumbnail Image

Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography 2017 - 2022

  • Report
  • 220 Pages
From
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant - Product Thumbnail Image

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • Report
  • 122 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 420 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

  • Drug Pipelines
  • 713 Pages
From
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • Drug Pipelines
  • 463 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  • Drug Pipelines
  • 515 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 434 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

  • Drug Pipelines
  • 346 Pages
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Drug Pipelines
  • 450 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

  • Drug Pipelines
  • 288 Pages
From
Renal Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Review, H1 2016

  • Drug Pipelines
  • 811 Pages
From
Renal Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Review, H1 2015

  • Drug Pipelines
  • 609 Pages
From
Loading Indicator
adroll